Sixfold bags VC funding for RNA delivery work
To view this email as a web page, click here

Today's Rundown

Featured Story

Visus closes in on AbbVie with midphase data on long-sightedness eye drop

Visus Therapeutics is coming for AbbVie. After ceding a big head start to AbbVie’s recently approved Vuity, Visus has posted midphase data that advance its effort to come from behind in the new market for medicines to treat age-related long-sightedness.

read more

Top Stories

PureTech's oral drug delivery work spawns clinical-phase challenger to Sage in depression

PureTech Health is stepping up its bid to challenge Sage Therapeutics for the depression market by moving a rival to Zulresso and zuranolone into the clinic. The study in healthy volunteers marks the start of PureTech’s effort to show its work to enable oral delivery translates into clinical benefits.   

read more

Sixfold bags VC funding to expand RNA delivery beyond the liver

Sixfold Bioscience has secured funding to support its effort to deliver RNA to previously untargetable tissues, pulling in $10.5 million from backers including Y Combinator and Cantos Ventures.

read more

Orexo unveils nasal EpiPen rival, sets sights on 2022 clinical trial

Orexo has joined the pack of drug delivery companies trying to improve on adrenaline autoinjectors such as EpiPen. The Swedish company has applied its amorphOX drug delivery platform to the challenge, resulting in a nasal adrenaline candidate it is pitching as more convenient than existing options.

read more

Moderna loses bid to invalidate vaccine delivery patents, teeing up potential infringement lawsuit

Moderna has suffered a blow in its patent feud with Arbutus Biopharma, exposing the mRNA specialist to a potential infringement suit on its megablockbuster COVID-19 vaccine. 

read more

Resources

Whitepaper: Patients Want Choice in Accessing and Participating in Clinical Trials

Create more inclusive clinical trials, enroll them faster, and keep participants engaged longer with the latest Study Voices survey results and insights.

Whitepaper: Tailored, Dedicated Support Expedites COVID-19 Vaccine Trial

Sites receiving augmentation support enroll more than 30,000 patients in just over three months. See how additional site resources can make a difference.

Whitepaper: QC for ex vivo manipulated cell lines and tissues

A variety of genetic analysis methods are valuable in ensuring that ex vivo human cells to be used for cell-based therapies are correctly identified, have the correct characteristics, and are free of contaminants.

Research: How Buffer Prep Services Alleviate Sudden Spikes in Campaign Volume

Learn how a CDMO partnered with Thermo Fisher Scientific to manage high-volume process liquid and buffer preparation scale-up. Download the free case study from Thermo Fisher Scientific

Whitepaper: Modernizing Key Clinical Trial Processes with Artificial Intelligence

This whitepaper addresses where AI can make the biggest impact in clinical trials. The stakes are too high for patients to leave decision-making to machines, but AI can lend administrative support that empowers staff and medical experts alike to carry out their jobs more effectively.

Guide: Top 10 Considerations When Implementing Machine Translation

If you’re thinking about leveraging the benefits of increased quality, reduced costs, and shortened turnaround times that machine translation (MT) has to offer, check out this quick guide for the top 10 considerations when implementing MT.

Whitepaper: Medable was able to cut costs in multiple clinical trials by over US$25,000,000

Find out how to improve clinical protocol adherence, and thus patient outcomes, by 15%+ with Medable’s latest White Paper.

Webinar: Using Next Best to Elevate your Omnichannel Marketing Strategy

Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making.

Whitepaper: Healthcare Technical Due Diligence: Assessing a New Cancer Treatment

A major Korean biopharmaceutical company wanted to gather unbiased opinions on a new cancer treatment product. Fill out our form to learn more.

Whitepaper: Demand Planning for New Drug/Device Combination

Download now to learn how GLG helped a biotech company plan for the demand of a new drug/device combination by commissioning a forecasting study.

Webinar: The Faster Path From Pre-Filled Syringe to Auto-Injector

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Whitepaper: Formulation Strategies When Transitioning From Vial to PFS

Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

2021 Report: Clinical Trial Management in a Post-Pandemic World

New market research provides valuable insight into the impact of adaptations made in clinical trials during the pandemic.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Content Hub: Remarque Systems Resource Hub

Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. 

Events